The serology of chronic hepatitis B infection revisited.
about
DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier stateCharacterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigensHepatitis B precore protein: pathogenic potential and therapeutic promiseMolecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: implications for occupational health practiceIgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis CImmunology of hepatitis B virus and hepatitis C virus infectionAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier.Humoral immune response in acute hepatitis C virus infection.Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice.Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapyPreferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent.The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.Interleukin-12 inhibits hepatitis B virus replication in transgenic mice.Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens.Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen.Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patientsCorrelation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.Chronic hepatitis B virus (HBV) infection in pregnancy.Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis BThe role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis BTherapeutic vaccination and novel strategies to treat chronic HBV infection.Use of hepadnavirus core proteins as vaccine platforms.The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.Atypical serological profiles in hepatitis B virus infection.HBV-Specific Adaptive Immunity.Tolerance and immunity to pathogens in early life: insights from HBV infection.Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection.Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.Antibodies to the hepatitis B e antigen (HBeAg) can be induced in HBeAg-transgenic mice by adoptive transfer of a specific T-helper 2 cell clone.Interleukin-12 in infectious diseases.Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infectionHepatitis B virus core particles as a vaccine carrier moiety.Interleukin-12: potential clinical applications in the treatment of chronic viral hepatitis.Pathobiology of acute and chronic hepatitis B virus infection: an introduction.Biological properties of interleukin-12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infection.Studies of interleukin-12 in chronic hepatitis B virus infection.Frequency-dependent selection drives HBeAg seroconversion in chronic hepatitis B virus infection.
P2860
Q24607288-54EA6777-1062-42D3-8FD8-D3E8039B6214Q24673500-B7B5AE90-599B-4A22-94A0-364B2F4F2E34Q26824158-A683F11B-7F21-4711-9F22-DF7652BBB202Q27477932-87E6D9C4-2320-41A7-A438-DEC02335FCC1Q27480600-85AB7CB3-70E2-4610-9056-D8631C74C991Q29618957-066DB068-983E-46F3-A399-638BC3729518Q30391932-B0D51DA7-BB98-4132-8B04-860D8764EA88Q33866045-1B3D915B-7F3F-413E-92F8-4260DFC1C44BQ33867720-EEFC23B3-2D3D-4FE3-88F0-4F01BCD15717Q33945175-C9C4791B-BD36-46DF-AFD2-2DBD0D0BBB87Q33989160-93B6B051-27E1-4C26-9B51-9A7483340F80Q34081375-299109EC-C812-485E-90A7-869B5CDCE092Q34151071-7D877287-3EFF-4E2A-9778-3D21C0FB89A7Q35838564-1ACADE6A-3FCA-4402-A77A-A429C91425B0Q35879066-C4C18EEF-C082-45C8-B318-BA7BB8E3CEFEQ35881471-C3440EB5-3064-4209-AE6B-A757D6B490ABQ35882104-D18D60EE-8855-4A79-90C4-B0E105FED408Q35887445-22F46472-261E-4CB4-AF87-E407D3CFEEA5Q36302694-1CDCF6AB-895E-4ECD-BBE0-8E5C4F0A77D2Q37099867-2A27DF74-8EBC-4B87-81D7-99BFDCAB5680Q37278254-9156B2C7-A16F-46A1-94C4-ACCF3598D948Q37369145-96E154FF-582D-4484-AD7A-D1E033954FC2Q37380078-A2DE4F7A-D0FC-4C4D-AA58-DFBED25128C9Q37611862-9C6F7ED1-364E-42A1-9CED-7B3DCA28C007Q37622906-12EB54E4-2E39-4032-8731-4790F513E3ADQ37748557-ABCA7F94-0990-4C9E-B019-98EBE4AE6A62Q38063427-B41B5598-A4E5-484F-95C2-05C2E11E6FD2Q38613247-C496379E-25F6-4223-B09D-869BBA8CA033Q39419957-B589EF23-FFC5-47EF-B4E5-90D8C5B7144AQ39592749-92C2D713-D630-4633-8718-A0ACF886D284Q39686280-97644404-C9B5-4010-B21F-0D4E7B60BDD7Q39811595-4B86D42B-DBCC-4B4D-9041-2A039DE65C7CQ39820841-EC3A6A4C-DDD8-4463-A3E4-7446B683CABBQ39870222-DD0A9960-2927-4093-8FC2-0541BDCDA451Q40391210-6930ED13-A400-402B-9930-72C6DB4CCAA3Q41428177-69BFCA4A-7CFA-4BB2-B100-F4775D4D36D4Q41681569-38B04237-D096-4C5D-A54E-E103F5D9B944Q41681591-C43256F7-A656-40D0-B525-600524E374C2Q41681599-801A858B-1C31-4F92-92B4-ED4133920745Q41767339-7902F896-94B9-4658-A4D0-1FDCC10FF61D
P2860
The serology of chronic hepatitis B infection revisited.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The serology of chronic hepatitis B infection revisited.
@ast
The serology of chronic hepatitis B infection revisited.
@en
type
label
The serology of chronic hepatitis B infection revisited.
@ast
The serology of chronic hepatitis B infection revisited.
@en
prefLabel
The serology of chronic hepatitis B infection revisited.
@ast
The serology of chronic hepatitis B infection revisited.
@en
P2093
P2860
P356
P1476
The serology of chronic hepatitis B infection revisited.
@en
P2093
P2860
P304
P356
10.1172/JCI116497
P407
P577
1993-06-01T00:00:00Z